Replies to post #131134 on NorthWest Biotherapeutics Inc (NWBO)

[forumreader35]

Interesting.

Any cell therapy that makes use of nucleic acids will have just as much as if not more difficulty than a cell therapy that utilizes protein.

Adding in another layer of processing with NGS, and proprietary special-algorithms sounds like a lot of work to come up with mRNA based signatures.

That seems like a harder sell than DCVax for approval.